Risk Assessment for Complex Systems Based on Fuzzy Cognitive Maps: A Case of the Biopharmaceutical Industry
Analyzing the supply chain (SC) of biopharmaceutical drugs can be challenging due to their complexity, the existence of a wide variety of risks, and the dynamics of the system. This paper presents a framework for evaluating the SC risks of Iranian biopharmaceutical companies based on cause-and-effec...
Saved in:
Main Authors: | Hadi Abbasian, Reza Yousefi-Zenouz, Abdollah Amirkhani, Masoud Shirzadeh, Akbar Abdollahiasl, Shekoufeh Nikfar, Mohammadreza Siahi-Shadabad, Abbas Kebriaeezadeh |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-01-01
|
Series: | Complexity |
Online Access: | http://dx.doi.org/10.1155/2024/4369401 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Automotive Electric Power Steering Control With Robust Observer Based Neuroadaptive Type-2 Radial Basis Function Methodology
by: Abdollah Amirkhani, et al.
Published: (2024-01-01) -
What are biopharmaceuticals?
by: Abhay H. Pande, et al.
Published: (2025-01-01) -
Plant-Derived Anti-Cancer Therapeutics and Biopharmaceuticals
by: Ghyda Murad Hashim, et al.
Published: (2024-12-01) -
Biopharmaceutical classification of desloratadine – not all drugs are classified the easy way
by: Berginc Katja, et al.
Published: (2020-06-01) -
Alternative buffer systems in biopharmaceutical formulations and their effect on protein stability
by: Lebar Blaž, et al.
Published: (2024-09-01)